Post-COVID Clinical Trial Performance Innovations

COVID has presented many challenges to the clinical trial industry over the past year.  These challenges have included:

• Moving from in-person to virtual events
• Difficulty in accessing clinical trial enrollees
• Ability to monitor the readiness of clinical trial investigators
• Reducing the variability of clinical trial execution

These challenges are not easily addressed by the same approaches leveraged in a pre-COVID operational framework.  The industry must adapt to the global “new normal”.

The Boston Consulting Group studies the performance of companies relative to their commitment to innovation.  They identified five key attributes to driving innovation for a company.   Those include:

1. Setting a clear ambition
2. Establishing the right playing fields
3. Prioritizing performance management
4. Pushing project management
5. Developing talent and culture

Pro-ficiency can be a key partner in improving clinical trial performance on all five dimensions.